Spyre Therapeutics (SYRE) Accounts Payables (2015 - 2026)
Spyre Therapeutics (SYRE) reported Accounts Payables of $5.72 million for Q2 2026, up 54.1% from $3.71 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Accounts Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics posted Accounts Payables of $8.9 million.
- Accounts Payables has a five-year compound annual growth rate of 31.6% (FY2020 to FY2025).
- By year, Accounts Payables came in at $666,000 in FY2024 (-25.7%), $896,000 in FY2023 (+32.3%), $677,000 in FY2022 (-79.6%) and $3.32 million in FY2021 (+47.2%).
- Five-year quarterly Accounts Payables spans a low of $666,000 in Q4 2024 and a high of $8.9 million in Q4 2025.
- Year over year, Accounts Payables gained in six of the last seven quarters, with growth averaging 52.7%.
- The high point for year-over-year Accounts Payables in five years was Q3 2024 (growth of 207.8%); the low point was Q4 2022 (a decline of 79.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.69 million (Q1 2026), $8.9 million (Q4 2025) and $7.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - | 5.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.72 Mn |
| Mar 31, 2026 | 5.69 Mn |
| Dec 31, 2025 | 8.90 Mn |
| Sep 30, 2025 | 7.46 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 666,000.00 |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 896,000.00 |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 2.85 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 677,000.00 |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 1.86 Mn |
API Access
Spyre Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();